Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer
- PMID: 24669009
- DOI: 10.1093/annonc/mdu125
Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer
Abstract
Background: Few nomograms can predict overall survival (OS) after curative resection of advanced gastric cancer (AGC), and these nomograms were developed using data from only a few large centers over a long time period. The aim of this study was to develop and externally validate an elaborative nomogram that predicts 5-year OS after curative resection for serosa-negative, locally AGC using a large amount of data from multiple centers in Japan over a short time period (2001-2003).
Patients and methods: Of 39 859 patients who underwent surgery for gastric cancer between 2001 and 2003 at multiple centers in Japan, we retrospectively analyzed 5196 patients with serosa-negative AGC who underwent Resection A according to the 13th Japanese Classification of Gastric Carcinoma. The data of 3085 patients who underwent surgery from 2001 to 2002 were used as a training set for the construction of a nomogram and Web software. The data of 2111 patients who underwent surgery in 2003 were used as an external validation set.
Results: Age at operation, gender, tumor size and location, macroscopic type, histological type, depth of invasion, number of positive and examined lymph nodes, and lymphovascular invasion, but not the extent of lymphadenectomy, were associated with OS. Discrimination of the developed nomogram was superior to that of the TNM classification (concordance indices of 0.68 versus 0.61; P < 0.001). Moreover, calibration was accurate.
Conclusions: We have developed and externally validated an elaborative nomogram that predicts the 5-year OS of postoperative serosa-negative AGC. This nomogram would be helpful in the assessment of individual risks and in the consideration of additional therapy in clinical practice, and we have created freely available Web software to more easily and quickly predict OS and to draw a survival curve for these purposes.
Keywords: advanced gastric cancer; external validation; multivariable analysis; nomogram; prognosis; survival analysis.
© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer.Cancer Commun (Lond). 2018 May 15;38(1):23. doi: 10.1186/s40880-018-0293-0. Cancer Commun (Lond). 2018. PMID: 29764518 Free PMC article.
-
Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.Int J Surg. 2016 Nov;35:153-159. doi: 10.1016/j.ijsu.2016.09.080. Epub 2016 Sep 21. Int J Surg. 2016. PMID: 27664559
-
Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.BMC Cancer. 2019 Aug 28;19(1):852. doi: 10.1186/s12885-019-6075-5. BMC Cancer. 2019. PMID: 31462229 Free PMC article.
-
Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.J Clin Oncol. 2012 Nov 1;30(31):3834-40. doi: 10.1200/JCO.2012.41.8343. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008291
-
Prognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review.Biomed Res Int. 2019 Sep 18;2019:5634598. doi: 10.1155/2019/5634598. eCollection 2019. Biomed Res Int. 2019. PMID: 31641669 Free PMC article.
Cited by
-
Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.Neuroendocrinology. 2015;101(1):58-65. doi: 10.1159/000371807. Epub 2015 Jan 5. Neuroendocrinology. 2015. PMID: 25572143 Free PMC article.
-
Current status of management of malignant disease: current management of gastric cancer.J Gastrointest Surg. 2015 Apr;19(4):782-8. doi: 10.1007/s11605-014-2707-x. Epub 2015 Jan 16. J Gastrointest Surg. 2015. PMID: 25591828 Review.
-
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.Cancer Cell Int. 2024 Jan 3;24(1):6. doi: 10.1186/s12935-023-03200-5. Cancer Cell Int. 2024. PMID: 38172873 Free PMC article.
-
Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China.Ann Surg Oncol. 2020 Mar;27(3):802-811. doi: 10.1245/s10434-019-08170-5. Epub 2020 Jan 1. Ann Surg Oncol. 2020. PMID: 31894481 Free PMC article.
-
Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Development of a Nomogram in Breast Cancer Patients.Front Oncol. 2021 Dec 17;11:650980. doi: 10.3389/fonc.2021.650980. eCollection 2021. Front Oncol. 2021. PMID: 34976782 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical